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er levels of pro-inflammatory cytokines and cortisol were 
identified in plasma and cerebrospinal fluid. However, to 
date it has not been clarified how peripheral inflammatory 
or endocrine biomarkers can reflect the likelihood or sever-
ity of delirium symptoms. In the future, a better understand-
ing of the interaction between the brain and peripheral or-
gans and the exact mechanism by which systemic inflamma-
tion can lead to delirium, will allow the development of new 
therapeutic agents.  © 2014 S. Karger AG, Basel
 Conceptual Overview
 Delirium refers to a cluster of cognitive, emotional and 
behavioural symptoms developing rapidly in the context 
of an underlying general medical condition and/or sub-
stance use considered to be aetiologically related to the 
symptoms  [1] . In addition to the core features of dis-
turbed consciousness with inattention, delirium mani-
fests with a global impairment in cognitive function (such 
as memory deficit, disorientation or language distur-
bance) and/or with perceptual disturbances which are not 
better accounted for by a pre-existing dementia  [1] . Ad-
ditionally, a range of neuropsychiatric symptoms are al-
most invariably present, including sleep-wake distur-
bance, lability of affect, delusions and motor disturbanc-
es. Delirium has typically an acute onset and symptoms 
fluctuate over the course of the day  [2] . This syndrome is 
particularly common in elderly subjects with acute medi-
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 Abstract
 Delirium is an acute neuropsychiatric syndrome character-
ized by acute-onset global cognitive deficits, perceptual and 
behavioural disturbances affecting mainly elderly subjects 
with underlying medical or surgical conditions. The patho-
physiology of delirium is complex and inflammation is a rel-
evant precipitant factor of this syndrome, although it re-
mains unclear how acute systemic inflammation induces the 
clinical picture of delirium. The central nervous system is 
able to detect peripheral infection or tissue destruction 
through circulating immune mediators and neural ascend-
ing signs. Activated microglia is responsible for an acute 
neuroinflammatory reaction underlying the symptoms of 
sickness. In healthy conditions descending pathways from 
the paraventricular nucleus, locus coeruleus and dorsal mo-
tor nucleus organize a centralized response to influence the 
immune response at the periphery and restore homeostasis. 
In the context of ageing and chronic neurodegeneration, 
adaptive changes to acute insults are characterized by exag-
gerated production of pro-inflammatory cytokines by 
primed microglia coupled with dysfunction of brain-to-im-
mune pathways. In animal models, these changes underlie a 
more severe manifestation of sickness behaviour with work-
ing memory deficits suggesting that inattention, a core fea-
ture of delirium, can be a clinical correlate of an increased 
neuroinflammatory reaction. In patients with delirium, high-
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cal conditions (e.g. urinary tract infection) or undergoing 
emergent surgical procedures. Despite being a transient 
disorder (lasting hours to days) delirium is associated 
with increased morbidity and mortality, higher risk of de-
mentia and acceleration of cognitive decline  [3–5] .
 Delirium Pathophysiology and Inflammation 
 The association between delirium and inflammation 
can be traced back to antiquity. In the  Hippocratic Corpus 
the most frequent term associated with the current con-
cept of delirium is ‘phrenitis’ which literally means ‘in-
flammation’ of the phrenes, the alleged seat of the soul 
 [6] . Since then, and for centuries, the presence of fever has 
been used as a criterion to distinguish mental changes 
secondary to physical illness (i.e. delirium) from other 
conditions  [7] . Currently, delirium pathophysiology is 
conceptualized as a state of acute and global disruption of 
the brain function as the result of the complex interplay 
between predisposing (e.g. advanced age, prior dementia) 
and precipitant factors. Most common precipitating fac-
tors of delirium are medications, infections, metabolic 
disorders, surgical procedures and primary central ner-
vous system (CNS) disorders. Subjects with a more vul-
nerable brain can develop delirium when exposed to even 
mild noxious stimuli (e.g. urinary infection). 
 A useful scheme to classify aetiological factors of de-
lirium is to consider whether there is evidence of direct 
brain involvement either selectively (e.g. neurological 
disorders) or as one of the multiple organs of the body 
that are involved (e.g. systemic inflammatory disorders). 
Many precipitant factors of delirium, while not occurring 
in the CNS, clearly affect essential physiological processes 
supporting brain function (e.g. hypoxia, anaemia, hypo-
glycaemia). The pathophysiological link between deliri-
um and a broad array of infectious and inflammatory ab-
normalities is more difficult to establish when these con-
ditions occur without identifiable involvement of the 
brain. Indeed, neither the origins of individual variability 
in response to inflammation nor the underlying mecha-
nisms by which the presence of inflammatory mediators 
in the bloodstream results in delirium are fully under-
stood. Moreover, how completely different aetiological 
causes may evoke similar symptoms has not yet been sat-
isfactorily explained. Yet, it is well established that during 
threatening conditions, such as infection or injury, it is 
indispensable that immunological responses are integrat-
ed in the full range of homeostatic mechanisms of the 
body. Consequently, the CNS and the peripheral immune 
system maintain a dynamic cross-talk to tightly co-ordi-
nate the innate immune response.
 In this review, we will delineate the mechanisms by 
which the CNS senses peripheral infection and tissue 
damage and how it provides a complex input to the innate 
immune system. This is crucial for an overall understand-
ing of how a dysregulated neural control of immunity can 
underlie the clinical syndrome of delirium. 
 Activation of the Immune and Nervous Systems 
following Acute Infection or Tissue Injury
 Local Activation and Regulation of the Innate 
Inflammatory Response during Infection or Tissue 
Injury
 The main trigger of inflammation is the recognition 
of highly conserved features of microbes (e.g. lipopoly-
saccharide, LPS, peptidoglycan) by ‘pattern-recognition 
receptors’, PRRs, expressed by resident immune cells. 
These PRRs include the cell-surface Toll-like receptors 
(TLRs) and cytosolic receptors collectively referred to as 
nucleotide-binding oligomerization domain-like (Nod-
like) receptors. In addition, a number of endogenous 
molecules that are released by necrotic cells (e.g. heat 
shock proteins, hyaluronan, β-defensin, uric acid crys-
tals) have been proposed to initiate the inflammatory 
process  [8] . Activation of TLRs initiates a conserved sig-
nalling cascade that culminates in the activation of NF-
κB and IFN-regulatory factor transcription factors in ac-
tivated phagocytes and mast cells. Release of pro-inflam-
matory cytokines (particularly TNF-α and IL-1) and 
other inflammatory mediators by these cells induce 
morphological and molecular changes in the adjacent 
structures such as endothelial cells  [9] . Within minutes 
to hours, circulating leukocytes, primarily neutrophils, 
are recruited to the site of damage and eliminate the mi-
crobe through phagocytosis  [10] . Anti-inflammatory 
signals, including lipid-derived mediators (e.g. lipoxins, 
arachidonic acid derivatives) and anti-inflammatory cy-
tokines, shift the response towards a state of resolution 
of inflammation and tissue clearance whenever the in-
fection or tissue damage is controlled  [9] . Appropriate 
regulation of these mechanisms is crucial to simultane-
ously protect the host and limit the damaging aspects of 
inflammation. 
 Immune Signal Transduction from the Periphery to 
the Brain 
 Being an organ crucial to survival, the brain continu-
ously monitors the immune state of the body and reacts 




















   
   
   
   
   
   
   
   
   

























nate immune response. Multiple pathways are involved 
in this communication between periphery and the brain. 
Pro-inflammatory cytokines produced in the infected/in-
jured organ are able to activate afferent nerves (e.g. vagus, 
trigeminus) which convey the signals to the brain  [11] . 
Also, recognition of PRRs can occur directly by immune 
cells located in circumventricular organs of the CNS. 
Moreover, circulating cytokines including IL-1, IL-6 and 
TNF-α can be actively transported across the blood-brain 
barrier, thus gaining access to the brain, or interact with 
receptors expressed by cerebral endothelial cells inducing 
the production of prostaglandin E2 into the brain paren-
chyma  [12] . Resident microglia, which in healthy condi-
tions remain in a quiescent state, express a multitude of 
surface receptors able to detect immune signals initiated 
at the periphery. Following activation, these cells initiate 
a neuroinflammatory reaction with the production of 
pro-inflammatory cytokines including IL-1, IL-6 and 
TNF-α, and chemokines such as monocyte chemoattrac-
tant protein-1 able to attract monocytes from the circula-
tion into the brain  [13, 14] .
 The Influence of Aging and Neurodegeneration 
 The normal aging process is associated with a shift in 
the inflammatory profile of the brain towards an overall 
pro-inflammatory environment and increased oxidative 
stress. Consistent with this, the aged brain of humans and 
rodents shows, in baseline conditions, an increased num-
ber of microglial cells with functional, morphologic and 
phenotypic features suggestive of an activated state  [15] . 
These age-related changes include upregulation of MHC 
class II, CD68, CD11b and CD11c integrins, TLR and co-
stimulatory molecule CD86(B7)  [16] . This microglia sub-
set, referred to as ‘primed’, has a more exuberant cytokine 
production in response to systemic inflammatory signals 
(e.g. LPS inoculation) compared to activated microglia 
from adult animals  [17] . The cause of this enhanced re-
sponsiveness to immune challenges is largely unknown 
but may involve a decreased microglial sensitivity to the 
anti-inflammatory signalling pathways (i.e. IL-10, TGFβ 
and IL-4)  [15] . Additionally, the aged brain shows, in 
baseline conditions, reduced levels of neuronally ex-
pressed proteins such as fractalkine ligand (CX3CL) and 
CD200, which have been implicated in microglial regula-
tion following acute activation. The interaction of these 
proteins with receptors exclusively located in microglia 
(CX3CR and CD200R) keep these cells in a resting state 
and attenuate their responsiveness to acute systemic in-
flammation  [15, 18] . Thus, it is likely that dysfunction in 
several regulatory systems underlie microglial senescence 
which results in a diminished capacity to perform their 
normal function and in a more toxic environment for the 
neural cells  [19] . Similarly, since the early stages of the 
disease, hippocampal microglia from murine models of 
neurodegeneration show a morphology and surface 
markers indicative of an activated state. These primed 
microglial cells react robustly to an acute systemic chal-
lenge with exaggerated synthesis of pro-inflammatory cy-
tokines  [13] .
 Descending Pathways from the Brain to the Immune 
System 
 During acute infection or injury the brain orchestrates 
a centralized response through activation of efferent net-
works including: (i) the hypothalamic-pituitary-adrenal 
(HPA) axis; (ii) the sympathetic nervous system (SNS), 
and (iii) the parasympathetic nervous system. 
 The HPA Axis 
 The paraventricular nucleus in the hypothalamus con-
tains the corticotropin-releasing factor cells that initiate 
the HPA response when activated by ascending and de-
scending signalling pathways following acute infection or 
injury  [20] . Among a diversity of stimuli known to acti-
vate the HPA axis, cytokines are particularly able to stim-
ulate the paraventricular nucleus acting both systemically 
or through paracrine/autocrine effects. Secretion of cor-
ticotropin-releasing factor into the portal venous system 
induces the release of adrenocorticotropic hormone 
(ACTH) in the anterior pituitary which in turn, when in 
circulation, stimulates glucocorticoid production from 
the adrenal cortex. Despite this axial conformation, pro-
duction of glucocorticoids during acute infectious/in-
flammatory insults is enhanced by direct actions of cyto-
kines within the pituitary and adrenal glands  [21] . Corti-
sol (in humans) and corticosterone (in rodents) are 
powerful anti-inflammatory agents and regulate the im-
mune response through binding either mineral corticoid 
receptors (type I) or glucocorticoid receptors (type II) ex-
pressed by immune cells. The sensitivity of the HPA axis 
to feedback inhibition by cortisol decreases with ageing 
 [22] and with dementia severity  [23] , resulting in a hyper-
activity of the axis and a slower recovery from acute stress. 
Also, increased adrenal sensitivity to ACTH has been 
documented in patients with dementia  [24] . Thus, in-
creased levels of plasma ACTH and plasma cortisol are 
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 The SNS 
 The SNS originates in nuclei within the brain stem, 
including the locus coeruleus, and gives rise to pregangli-
onic efferent fibres through the thoracic and lumbar spi-
nal nerves. These fibres terminate primarily in the supe-
rior cervical ganglia, stellate ganglia, superior mesenteric 
ganglia and celiac ganglia, from which postganglionic 
sympathetic fibres run to the tissues innervated, includ-
ing lymphoid organs. During an immune response cyto-
kines such as IL-1, IL-6, and TNF-α can trigger activation 
of both the SNS and the HPA axis  [26] . Activation of the 
SNS system leads to increased release of norepinephrine 
from the varicose sympathetic nerve terminals and epi-
nephrine from the adrenal medulla. Catecholamines ex-
ert predominantly anti-inflammatory effects targeting α- 
and β-adrenergic receptors expressed by monocytes, 
macrophages and lymphoid cells  [27] .
 The Parasympathetic Nervous System 
 The ‘inflammatory reflex’ is a neural pathway com-
prising both afferent and efferent fibres of the vagus 
nerve that senses systemic inflammation and transmits 
anti-inflammatory signals to modulate the innate in-
flammatory response at the periphery. The dorsal motor 
nucleus of the vagus is the origin of the descending pre-
ganglionic fibres referred to as the ‘cholinergic anti-in-
flammatory pathway’. Activation of the vagus nerve in-
duces the release of acetylcholine at the periphery, par-
ticularly in the spleen, which is a highly innervated 
secondary lymphoid organ and a major source of TNF-α 
during endotoxaemia  [28] . Through inhibition of NF-κB 
nuclear translocation and activation of Jak-STAT path-
ways, acetylcholine attenuates the production of TNF, 
IL-1β, IL-6 and IL-18 immune cells expressing the nico-
tinic acetylcholine receptor subunit α7. In resting condi-
tions, the set point of this reflex arch contributes to es-
tablish the magnitude of the innate inflammatory re-
sponse to acute infection/injury. An additional input 
required for attenuation of systemic cytokine production 
is norepinephrine release from splenic nerve endings 
 [28] .
 In summary, infection or tissue destruction induces 
the production and release of inflammatory mediators, 
both at the periphery and in the brain with subsequent 
activation of the HPA axis and descendent sympathetic 
and parasympathetic fibres. Cortisol, norepinephrine, 
other endocrine mediators and acetylcholine regulate the 
actions of pro-inflammatory cytokines providing a bi-di-
rectional interaction between the brain and the immune 
system at the periphery. 
 Clinical Correlates of Acute Neuroinflammation
 The cognitive and behavioural consequences of im-
paired immunoregulation have been intensively studied 
and recent evidence indicates that systemic inflammation 
translates into acute neuropsychiatric symptoms and ac-
celeration of chronic cognitive impairment. 
 Animal Studies
 Peripheral challenges with bacterial LPS or double-
stranded RNA (poly I:C) in animal models have been 
particularly useful in clarifying the role of systemic in-
flammation in the emergence of acute neurocognitive 
and behavioural symptoms. Elevated levels of TNF-α 
or IL-1 (but not IL-6 or IFN-γ) in the CNS following 
acute systemic inflammation are responsible for a clus-
ter of transient and stereotyped changes known as 
‘sickness behaviour’. This syndrome mimics the symp-
toms experienced by humans during a viral or bacte-
rial infection and manifests with decreased levels of so-
cial exploration, locomotor activity and sweetened liq-
uid or food intake  [29] . Aged mice show enhanced 
production of pro-inflammatory cytokines in the brain 
after LPS stimulation and this translates into a more 
severe sickness. In contrast, the symptoms are attenu-
ated by IL-10  [30] . Importantly, upregulation of in-
flammatory mediators such as IL-1, TNF-α, type I in-
terferons and COX-2 in the brain following challenge 
with systemic LPS have been directly implicated in in-
ducing transient working memory deficits (a proxy of 
delirium)  [31, 32] . The development of acute atten-
tional deficits was associated with pre-existing hippo-
campal synaptic loss, microglial priming or moderate 
basal forebrain cholinergic hypofunction  [31–33] . All 
these changes, which leave the brain more susceptible 
to inflammatory insults, are also known to underlie 
major predisposing factors of delirium such as in-
creased age and dementia. Furthermore, an increased 
number of apoptotic cells were observed in the brains 
of ME7 mice suggesting that the acute neuroinflamma-
tory events not only produce transient symptoms but 
have long-term irreversible consequences  [31, 32] . 
Multiple neuroanatomical regions and neurochemical 
changes are likely to be involved in the transduction of 
inflammatory signals into cognitive, motor and moti-
vational symptoms. Regions known to express IL-1 
and TNF-α receptors include the dentate gyrus, hippo-
campus, anterior pituitary gland, endothelial brain 
cells, hypothalamus, cortex, nucleus of the solitary 




















   
   
   
   
   
   
   
   
   


























 Elevated levels of plasma C-reactive protein have been 
reported in patients with delirium in medical or surgical 
settings  [34, 35] but this has not been confirmed by other 
studies  [36–38] . Similarly, reports of higher plasma levels 
of IL-6, IL-8 and IL-10 in patients with delirium were not 
consistently replicated. In a case-control study only IL-8 
(but not IL-1b, IL-6, IL-10 IL-12p70 and TNF-α) was 
found to be increased in cerebrospinal fluid of patients 
with pre- or postoperative delirium  [39] . On the other 
hand, brains of patients who develop delirium near to 
death show higher microglial and astrocytic activation 
coupled with increased levels of IL-6 compared with age-
matched controls without delirium  [40] . Also, one study 
reported that subjects who developed delirium had a 
higher ratio of pro-inflammatory to anti-inflammatory 
cytokines following elective arthroplasty  [41] . This sug-
gests that rather than isolated plasma or cerebrospinal 
fluid levels of cytokines, the combined monitoring of dif-
ferent inflammatory mediators may better capture the 
complex homeostatic dysfunction occurring during a de-
lirium episode. In the same study, a positive correlation 
was found between baseline plasma cholinesterase activ-
ity and the magnitude of the inflammatory response fol-
lowing surgery in delirium subjects but not in controls 
 [41] . It is possible that plasma cholinesterase activity re-
flects the inhibitory cholinergic tone at the periphery and 
that a hyperactive cholinergic anti-inflammatory path-
way underlies the greater strength of correlation between 
plasma cholinesterase activity and the inflammatory re-
sponse observed in individuals with delirium  [41] .
 Acute systemic inflammation has also been implicated 
in the pathophysiology of dementia with abundant clinical 
and neuropathological evidence showing that pre-existing 
dementia significantly increases the susceptibility of the 
CNS to the deleterious effects of acute systemic inflamma-
tion. In patients with Alzheimer’s disease a raised pro-in-
flammatory cytokine profile over 6 months was associated 
with an approximately 2-fold increased frequency of neu-
ropsychiatric features characteristic of sickness behaviour. 
Thus, anxiety and depression were more commonly ob-
served in subjects with elevated serum TNF-α levels while 
the occurrence of apathy was associated with raised plasma 
levels of IL-6  [42] . In addition, acute systemic inflamma-
tory events and elevated TNF-α were associated with an 
increased rate of cognitive decline  [43] . It remains to be 
established to what extent episodes of acute systemic in-
flammation (i.e. viral or bacterial infection) overlap with 
episodes of delirium and contribute to the poor cognitive 
outcome associated with delirium in the long term.
 As stated above, there is a bi-directional interaction 
between acute systemic inflammation and the activation 
of the HPA axis. Cortisol levels have been found to be el-
evated in plasma and cerebrospinal fluid of patients with 
delirium in a diversity of medical and surgical conditions 
in line with the hypothesis of an ‘aberrant stress response’ 
of delirium  [44–46] . However, it remains unclear if cor-
tisol elevation is the result of a primary dysfunction of the 
HPA axis or represents a secondary change to a more in-
tense inflammatory reaction. In any case, increased levels 
of corticosteroids have a direct negative impact on cogni-
tion, including declarative and working memory, which 
can underlie some features of delirium  [47] .
 Summary and Conclusions
 The evidence reviewed so far shows that acute system-
ic inflammation elicits a prompt neuroinflammatory
reaction in the CNS largely mediated by activated mi-
croglial cells. The production of pro-inflammatory cyto-
kines including IL-1 and TNF-α induces a cluster of be-
havioural, cognitive and motivational changes which, in 
physiological conditions, are necessary to co-ordinate a 
centralized response to combat potential threats occur-
ring at the periphery. Once homeostasis is regained, the 
symptoms of sickness resolve and the behaviour returns 
to normal. However, an unbalanced neuroinflammatory 
response with exaggerated and prolonged production of 
pro-inflammatory cytokines can cause more severe neu-
rochemical and functional disturbances affecting neural 
function and long-lasting structural damage with neuro-
nal cell loss. Even normal levels of acute systemic inflam-
mation can induce such hazardous events when the brain 
has become more vulnerable due to the effects of aging 
and/or chronic neurodegeneration. In both conditions, 
there is a shift towards a pro-inflammatory state in base-
line conditions and a dysregulation of homeostatic re-
sponses to infection/inflammation. Microglial hyper-re-
sponsiveness to acute peripheral inflammation manifests 
with exacerbated sickness behaviour and working mem-
ory deficits in experimental conditions. Thus, it has been 
proposed that delirium is a maladaptive equivalent to 
sickness behaviour due to the combined effect of promi-
nent acute neuroinflammation and reduced functional 
reserve of the brain ( fig. 1 ).
 Taken together, the data reviewed here suggests that 
acute systemic inflammation can have a major impact in 
the brain and can mediate the relation between increasing 
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tion between delirium and cognitive deterioration in the 
long term. Full understanding of these pathophysiologi-
cal mechanisms would be crucial to develop sensitive and 
specific biomarkers monitoring the progression of chang-
es underlying delirium. Indeed, there is a compelling 
need to predict the risk of delirium and further cognitive 
decline in subjects with dementia exposed to acute in-
flammation. In a typical acute medical ward there may be 
dozens of patients infected with bacteria, but the magni-
tude of the innate immune responses will vary consider-
ably, spanning from having no observable inflammation 
to the release of pro-inflammatory cytokines that mediate 
tissue injury and delirium. However, the evidence relat-
ing inflammation to delirium is difficult to translate into 
clinical practice as the relationship between the absolute 
levels of serum inflammatory mediators and clinical 
symptoms is inconsistent. Future studies are also needed 
to address the possibility that dysfunctional neural cir-
cuits affected by the on-going neurodegenerative process 
could alter systemic innate immune responses. Similarly, 
there is a lack of studies analysing the interconnection 
between the innate immune response and brain-to-im-
mune pathways in subjects before, during and after de-
lirium. Finally, the progressive understanding of the in-
teraction between the brain and peripheral organs could 
lead to the development of new therapeutic agents  [48] .
 
 Fig. 1. Pathophysiological pathways potentially implicated in the 
relationship between delirium and inflammation. 
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